Amanote Research

Amanote Research

    RegisterSign In

Will Drug Resistance Against Dolutegravir in Initial Therapy Ever Occur?

Frontiers in Pharmacology - Switzerland
doi 10.3389/fphar.2015.00090
Full Text
Open PDF
Abstract

Available in full text

Categories
Pharmacology
Date

April 29, 2015

Authors
Mark A. WainbergYing-Shan Han
Publisher

Frontiers Media SA


Related search

Barrier to Resistance of Dolutegravir in Two-Drug Combinations

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2019English

Drug Resistance in Cancer Therapy

Drug Delivery and Translational Research
Pharmaceutical Science
2011English

All That Ever Will Be …

Journal of the American Water Works Association
Water ScienceChemistryTechnology
2019English

When Will We Ever Learn?

Annales Universitatis Mariae Curie-Sklodowska, sectio FF, Philologia
2017English

Will Chinese Industry Ever Be ‘Green’?

2013English

Will the War on Terror Ever End?

Revue des droits de l’homme
2019English

Will We Ever Stop Using Fossil Fuels?

Journal of Economic Perspectives
EconomicsEconometrics
2016English

Will There Ever Be a Food and Drug Administration-Approved Device for Transcatheter Paravalvular Leak Closure?

Circulation: Cardiovascular Interventions
Cardiovascular MedicineCardiology
2014English

Nanomedicine: Will It Be Able to Overcome Multiple Drug Resistance in Cancer?

Madridge Journal of Nanotechnology & Nanoscience
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy